Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
Wei Zhu, Zeenat A. Shyr, Donald C. Lo, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 378, Iss. 2, pp. 166-172
Open Access | Times Cited: 23

Showing 23 citing articles:

Therapeutics for COVID-19
Sima S. Toussi, Jennifer Hammond, Brian S. Gerstenberger, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 771-786
Open Access | Times Cited: 66
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
Lennart Brewitz, Leo Dumjahn, Yilin Zhao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2663-2680
Open Access | Times Cited: 46
Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination
Jordi Reina, Carla Iglesias
Revista Española de Quimioterapia (2022) Vol. 35, Iss. 3, pp. 236-240
Open Access | Times Cited: 49
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19
Arun K. Ghosh, Jennifer L. Mishevich, Andrew D. Mesecar, et al.
ChemMedChem (2022) Vol. 17, Iss. 22
Open Access | Times Cited: 44
Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine
Tika R. Malla, Lennart Brewitz, Dorian-Gabriel Muntean, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7682-7696
Open Access | Times Cited: 31
Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease
Chunsong Hu
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease
Rui Zhang, Jiahao Zhou, Haohao Yan, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 3
Open Access | Times Cited: 4
Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease
Lennart Brewitz, Jos J. A. G. Kamps, Petra Lukacik, et al.
ChemMedChem (2022) Vol. 17, Iss. 9
Open Access | Times Cited: 20
Fullerenes against COVID-19: Repurposing C60 and C70 to Clog the Active Site of SARS-CoV-2 Protease
Tainah Dorina Marforio, Edoardo Jun Mattioli, Francesco Zerbetto, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1916-1916
Open Access | Times Cited: 16
Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
Larysa V. Yevsieieva, Kateryna Lohachova, Alexander Kyrychenko, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35500-35524
Open Access | Times Cited: 9
Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches
Muhammad Waqas, Saeed Ullah, Atta Ullah, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134476-134476
Closed Access | Times Cited: 2
Sesquiterpene coumarins of Asafoetida mask the functional site of pathogenic proteins of SARS-CoV-2 to combat COVID-19 disease
Surekha Ramachandran
Annals of Phytomedicine An International Journal (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Liposome-Mediated Delivery of MERS Antigen Induces Potent Humoral and Cell-Mediated Immune Response in Mice
Masood Alam Khan, Ajamaluddin Malik, Mohammad A. Alzohairy, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 403-403
Open Access | Times Cited: 7
Significance of understanding the genomics of host–pathogen interaction in limiting antibiotic resistance development: lessons from COVID-19 pandemic
Vikas Yadav, Srividhya Ravichandran
Briefings in Functional Genomics (2023) Vol. 23, Iss. 1, pp. 69-74
Closed Access | Times Cited: 3
Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19
Karol Biernacki, Olga Ciupak, Mateusz Daśko, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 2
Pharmacophore-Based Virtual Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Library of Natural Products
Jing Wang, Yu Jiang, Yingnan Wu, et al.
Natural Product Communications (2022) Vol. 17, Iss. 12
Open Access | Times Cited: 4
Validation of baicalein and oridonin as nonspecific SARS‐CoV‐2 main protease inhibitors
Haohao Yan, Rui Zhang, Gangan Yan, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 3, pp. 1161-1164
Closed Access | Times Cited: 2
Four new eudesmane-type and one new eremophilane-type sesquiterpenes from the whole plant of Carpesium abrotanoides L.
Yu-Wen Fan, Wei-Jie Zhang, Zhuo-Yi Ao, et al.
Fitoterapia (2023) Vol. 169, pp. 105548-105548
Closed Access | Times Cited: 1
Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking
Luis Castillo-Campos, José Luis Velázquez‐Libera, Julio Caballero
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 1
The sesquiterpenes with the COVID-19 M pro inhibitory activity from the Carpesium abrotanoides L.
Yu-Wen Fan, Zhuo-Yi Ao, Wei-Jie Zhang, et al.
Natural Product Research (2023) Vol. 38, Iss. 11, pp. 1909-1917
Open Access | Times Cited: 1
The current state of validated small molecules inhibiting SARS-CoV-2 nonstructural proteins
Fatih Kocabaş, Merve Uslu
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 469-483
Open Access | Times Cited: 2
Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses
Grigore Mihăescu, Mariana Carmen Chifiriuc, Corneliu Ovidiu Vrâncianu, et al.
Microorganisms (2021) Vol. 9, Iss. 12, pp. 2578-2578
Open Access | Times Cited: 2


Revista Española de Quimioterapia (2022) Vol. 35, Iss. 3
Open Access
Page 1

Scroll to top